Overview

Ropivacaine 0,2% Plus Dexamethasone Versus Ropivacaine 0,2% Plus Placebo in Modified Pectoral Block

Status:
Recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
To find out if dexamethasone used as adjuvant to ropivacaine, a long-lasting local anesthetic, prolongs the duration of modified pectoral nerve block in women undergoing breast surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Medical University Innsbruck
Treatments:
BB 1101
Dexamethasone
Dexamethasone acetate
Ropivacaine